| Name | Title | Contact Details |
|---|
Antelope Valley Hospital, the only full-service, acute-care hospital in the Antelope Valley, has been delivering exceptional care to the community for more than 60 years. It offers the regions only trauma center, pediatric unit, NICU, inpatient mental health care, labor and delivery, Accredited Chest Pain Center/STEMI Receiving Center, Advanced Primary Stroke Center and Comprehensive Community Cancer Center.
Gradworks-Lifecycle marketing and Education is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Robert Half, the world`s first and largest specialized talent solutions firm, connects opportunities at great companies with highly skilled job seekers. We offer contract, temporary and permanent placement solutions for roles in finance and accounting, technology, marketing and creative, legal, and administrative and customer support. Named to Fortune`s World`s Most Admired Companies and 100 Best Companies to Work For® lists and a Forbes Best Employer for Diversity, Robert Half is the parent company of Protiviti®. Robert Half is traded on the New York Stock Exchange (symbol: RHI) and is a member of the S&P 500 index.
At MELA Sciences, we design and develop innovative software-driven medical technologies for physician clinical use during the detection of skin cancers at the most curable and cost-effective stages. Our mission is to develop breakthrough medical technologies to improve skin cancer detection and achieve better outcomes for all. We envision a world in which our pioneering innovations will change the way patients think about skin cancer, while providing dermatologists and clinicians with new, effective, non-invasive tools for the earliest detection possible. MELA Sciences conducted the largest, positive prospective study ever done on the melanoma disease, and is the first and only medical technology company to receive both FDA Pre-Market Approval (PMA) for the U.S. and CE Marking certification for the European Union for a device of this nature. The company’s flagship product, MelaFind®, is intended to provide dermatologists with software-driven image analysis of clinically atypical pigmented skin lesions when they choose to obtain additional information to help decide whether to biopsy or not. The FDA has approved MELA Sciences’ MelaFind® Pre-Market Approval application for use in the United States and MELA Sciences has also been granted CE Mark approval for sale of MelaFind® in the European Union.
BodyTel is a Reno, NV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.